Chen, Jia-Shiong
Chou, Cheng-Han
Wu, Yi-Hong
Yang, Mu-Hsuan
Chu, Sz-Hao
Chao, Ye-Su
Chen, Chia-Nan
Article History
Received: 5 February 2021
Accepted: 5 January 2022
First Online: 20 January 2022
Competing interests
: JS-C, CH-C, YH-W, MH-Y, SH-C, YS-C, and CN-C are employees of GNTbm; JS-C, YS-C, and CN-C are stakeholders in GNTbm. JS-C, CH-C, YH-W, YS-C, and CN-C are currently applying for patents covering the combination of chidamide plus celecoxib with immunotherapies.